Quincy Bioscience
Conducts research and development using a patented platform technology called apoaequorin, which comes from jellyfish and has been proven to protect brain cells and improve memory. Its compounds are used to treat neurodegenerative disorders such as Alzheimer's and Lou Gehrig's disease.
2012 STATISTICS
3-year growth:937%
2011 Revenue:$12.7 million
2008 Revenue:$1.2 million
Employees:58
Jobs added, prev. 3 years:38
2012 HONORS
#31
Top 100 Health Companies
#2
Top 100 Wisconsin Companies
